Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Friedland

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Drug and Alcohol Dependence|July 24, 2007
Interaction between buprenorphine and atazanavir or atazanavir/ritonavirElinore F McCance-Katz, David E Moody, Gene D Morse, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|November 7, 2015
Reducing Loss to Follow-Up with Tele-audiology Diagnostic EvaluationsMadan Dharmar, Anne Simon, Candace Sadorra, et al.
The Journal of Infectious Diseases|January 6, 2005
Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8Edana Cassol, Taryn Page, Anisa Mosam, et al.
AIDS and Behavior|October 12, 2023
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First COVID-19 Wave: A Cross-sectional SurveyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
Clinical Pharmacokinetics|January 7, 2005
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individualsPatrick F Smith, Robert Dicenzo, Alan Forrest, et al.
AIDS Care|May 2, 2008
Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical careWynne E Norton, K Rivet Amico, William A Fisher, et al.
The Journal of Infectious Diseases|October 14, 2008
Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South AfricaJason R Andrews, Neel R Gandhi, Prashini Moodley, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 19, 2011
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosisQuarraisha Abdool Karim, Salim S Abdool Karim, Cheryl Baxter, et al.
Open Forum Infectious Diseases|July 12, 2017
Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control EffortsSheela V Shenoi, Anthony P Moll, Ralph P Brooks, et al.
HIV Medicine|October 11, 2021
Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIVJessica J Tuan, Heidi Zapata, Terese Critch-Gilfillan, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Drug and Alcohol Dependence|July 24, 2007
Interaction between buprenorphine and atazanavir or atazanavir/ritonavirElinore F McCance-Katz, David E Moody, Gene D Morse, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|November 7, 2015
Reducing Loss to Follow-Up with Tele-audiology Diagnostic EvaluationsMadan Dharmar, Anne Simon, Candace Sadorra, et al.
The Journal of Infectious Diseases|January 6, 2005
Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8Edana Cassol, Taryn Page, Anisa Mosam, et al.
AIDS and Behavior|October 12, 2023
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First COVID-19 Wave: A Cross-sectional SurveyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
Clinical Pharmacokinetics|January 7, 2005
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individualsPatrick F Smith, Robert Dicenzo, Alan Forrest, et al.
AIDS Care|May 2, 2008
Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical careWynne E Norton, K Rivet Amico, William A Fisher, et al.
The Journal of Infectious Diseases|October 14, 2008
Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South AfricaJason R Andrews, Neel R Gandhi, Prashini Moodley, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 19, 2011
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosisQuarraisha Abdool Karim, Salim S Abdool Karim, Cheryl Baxter, et al.
Open Forum Infectious Diseases|July 12, 2017
Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control EffortsSheela V Shenoi, Anthony P Moll, Ralph P Brooks, et al.
HIV Medicine|October 11, 2021
Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIVJessica J Tuan, Heidi Zapata, Terese Critch-Gilfillan, et al.
Pageof 11